Thromb Haemost 2015; 114(02): 432-433
DOI: 10.1160/TH15-01-0082
Author Correspondence
Schattauer GmbH

Carbon monoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329–337)

Authors

  • Agnieszka Loboda

    1   Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
    2   Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland
  • Alicja Jozkowicz

    1   Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
  • Jozef Dulak

    1   Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
Further Information

Publication History

Received: 28 January 2014

Accepted after minor revision: 26 February 2015

Publication Date:
29 November 2017 (online)